Part 2 7.Ensure that :- A.The Patient is put on treatment as early as possible. B.The patient completes the full course of treatment. C.The Patient is.

Slides:



Advertisements
Similar presentations
TB: A Global Emergency 1/3 of the world (2 billion people) infected 1 person infected/second resulting in >30 million new infections, 8 million new cases.
Advertisements

Implementing a TB-Control Program in Prisons: The Basics Dr. Mayra Arias.
Dr. Essam El Moghazy NTP Egypt
ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Your name Institution/organization Meeting Date. Introduction.
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Diagnosis of Smear negative pulmonary TB in high HIV settings: RESEARCH PRIORITIES Haileyesus Getahun, Stop TB, WHO. Expert consultation on TB/HIV research.
Module 11: Community TB Care Image source: Pierre Virot, World Lung Foundation.
Improving diagnosis TB laboratory strengthening.
Of South Africa DOTS WORKS VWSA WORKPLACE PROGRAM.
Decentralisation as a Strategy to Address Major Challenges of DOTS Services: Experience of Kano State, Nigeria Mahmoud Nasir Mohammed 1, Tijjani Hussaini.
Using the Supervisory Checklist Module 9 Part B. How do I monitor? The supervisory checklist gives you a structure you can use … … but it should not limit.
ARIAtlas.org. Global Impact TB causes nearly two million deaths a year, making it the world’s seventh most common cause of mortality. More than two billion.
Introduction India has the highest burden of tuberculosis in the world, with an estimated 2 million cases annually, accounting for 1/5 th of global incidence.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
Role of the community/volunteers in the delivery of the TB/HIV package: David Coetzee February 2005 UNIVERSITY OF CAPE TOWN School of Public Health and.
KEY CHANGES IN THE NEW NTBLCP GUIDELINES
Monitoring and Evaluation: Tuberculosis Control Programs
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Nepal TB REACH Project Wave 2 Year 1 (Nov Dec 2012) Year 2 (Jan 2013 – Jun 2014)
National Tuberculosis Control Program
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2013
Monitoring & Evaluation of RNTCP
Revised National Tuberculosis Control Programme (RNTCP)
Diagnosis of TB.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Plans for Diagnosis and Management of Acute Pyelonephritis.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2014
Role of Pharmacist in Malaria Control
Partnerships to Prevent, Find and Treat TB/DRTB and HIV 12 October 2010 Prof Harry Hausler, Director.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
Activities in Project Axshya (GFR 9 TB project)
“Don’t tell me TB is under control!” Understanding TB
DEPARTMENT OF HEALTH DOTS Program for TB (Tuberculosis Directly Observed Short-course)
Monitoring and Evaluation Module 12 – March 2010.
Cases and Rates in 1991 Table 6 Population: ? New SM +: N = 8,507 All Cases: N = 10,903 Table 8 Population: ? New SM +: N = 8,835 All cases: N = 10,872.
Extrapulmonary Site 2 :_____________________ Name (surname, first name) Age (in years) Sex F Alternative address Physical Address (in full) M INTERIM TUBERCULOSIS.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Unit 12: Reporting & Recording Botswana National Tuberculosis Programme Manual Training for Medical Officers.
B.L.TEJASWI INTERN JJMMC. Which is the biggest disease today ?????
DOTS-PLUS IN TANZANIA: PREPARATION PHASE Global DOTS Expansion Working Group Meeting, Paris: 28 October 2004 NTLP - MOH Prepared by: Dr. S. M. Egwaga NTLP.
Revising the WHO TB Treatment Guidelines Process and new recommendations Malgosia Grzemska Matteo Zignol Stop TB Department World Health Organization DEWG.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Welcomes HONOURABLE VISITORS Dr.S.K.SRIVASTAVA MEMBER SECRETARY.
Extrapulmonary Site 2 :_____________________ TUBERCULOSIS TREATMENT CARD BOTSWANA NATIONAL TUBERCULOSIS PROGRAMME Date RegisteredIN ToOUT RegisteredIN.
Module 2 TB Disease Transmission & Prevention. Pulmonary Tuberculosis Extra -Pulmonary TB an infectious disease caused by a microorganism called Mycobacterium.
Tuberculosis control in Suriname Situational analysis.
Unit 11 Drug Resistance and MDR-TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
Introducing fixed dose combination tablets into DR CONGO using the Global TB Drug Facility.
Roundtable. Detection and treatment of TB Andrew Black.
Rauni Ruohonen FILHA Priorities of TB control in penitentiary care.
TB- HIV Collaborative activities in Romania- may 2006 status
Summary of changes in the RNTCP technical guidelines in
NURSES ROLE IN THE CARE AND MANAGEMENT OF MDR-TB
Fifth Pacific Stop TB meeting Fiji Islands, May 4-7, 2010
Presentation 10 Analysing results and defining cases
بسم الله الرحمن الرحيم.
Implementing a TB-Control Program in Prisons: The Basics
Community Pharmacists Monitoring of Pulmonary Tuberculosis Outpatients (Preliminary Study)
Tuberculosis in children BY MBBSPPT.COM
TB epidemiological situation in Kyrgyzstan
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
Mentoring CHV Supervisors to Ensure Treatment Adherence of TB Patients
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
The STOP TB Strategy – 2009 VISION: A TB-free world
5th edition NTP MANUAL OF PROCEDURES TB-DOTS Referral System
Presentation transcript:

Part 2

7.Ensure that :- A.The Patient is put on treatment as early as possible. B.The patient completes the full course of treatment. C.The Patient is subjected to follow up sputum Exams as per Schedule. D.The Patient must be subjected to the last follow up sputum exam.

7.Always give a course of Non- tubercular broad spectrum antibiotics for days 8.Always take a good history of previous treatment 9. Good classification of cases ensures better treatment & better outcome.

Diagnosis of Pulmonary Tuberculosis 1.Patients with T.B.feel ill and seek care promptly. 2.Active case finding is unneccesary&unproductive. (No Use of Organising Camps,Their only use is political)

3.Microscopy is appropiate technology,indicating infectiousness,risk of death,&priorityfor treatment. X-ray is non-specific for T.B.diagnosis. 4.Serological & amplification technologies(PCRetc) currently of no proven value in T.B.Control.

Role of Chest X-Ray a)No chest X-Ray pattern is typical of T.B. b)10-15 % of culture- positive T.B.patients are not diagnosed by X-Ray. (K.TOMAN-1997)

c) 40 % of patients diagnosed as having T.B. on the basis of x-ray alone do not have active T,B. Conclusion:-Xray is unreliable for diagnosing and monitoring treatment of Tuberculosis (K.TOMAN-1997)

Objectivity & Reliability of Microscopy V/S X-Ray (inter observer Agreement)

Specificity of sputum Examination v/s Chest X-Ray Examination

Role of THREE Sputum Exams. (Three Sputum Smears are Optimal)

No of Bacilli SeenResult Reported NONE per oil immersion field.Negative 1-9 per 100 oil immersion fields Scanty,Report Exact number per 100 oil immersion fields per oil immersion fields2+ >10 per oil immersion field3+

Priority to Sput. +ve cases WHY ? 1.Smear positive patients usually seek care. 2.Smear positive patients are 4-20 times more infectious

3.Untreated, a smear +ve patient may infect persons / year. 4.Smear positive patients are much more likely to die if left untreated.

Treatment Regimens of N.T.P Standard-Conventional Regimens:-(Inj under supervision,Drugs issued monthly) R-1 All New Pulmonary Sputum Positive Cases 2STH / 10 TH or 2SEH / 10 EH R-2 All Pulmonary Sputum Negative Cases &Extra- Pulmonary cases 12 TH or 12 EH (contd)

Short Course Chaemotherapy(Inj Under supervision,Drugs issued fortnightly) R-A All New Pulm.Sputum +ve cases 2EHRZ /6 TH OR 6 EH R-B All Retreatment cases(Relapse,Failure,T.A.D.) 2SHRZ / S2H2R2 (Intensive phase under Supervision)

Improvements in R.N.T.C.P. 1.Societies formed at State & distt to facilitate flow of funds. 1.Burden of diagnosing &completing treatment of the patient is on the service provider,not on the patient.

2.The patient is now a V.I.P. 3.The programme has been decentralized to a level of virtual T.B.Clinic at a popln.of 5 Lakhs & upto the level of DOT centres (popln. of ).

4.Diagnosis is through a Diagnostic Algorhythm which gives the maximum yield of T.B.patients.

5.Emphasis is now on a better tool of diagnosis viz-SPUTUM EXAMINATION,that too with a Binocular microscope and with 3 sputum specimens.

6.Treatment is by standarized regimens(Categories) 7.Almost all the doses are by means of DOTS.

8Default retrieval by means of a well developed system consisting of:- a)Registration of only those patients who reside within distt. b)checking of addresses before doing registration. c)Default retrieval of all the patients within a maximum of 2 days(before the next dose)

9.Supply of drugs in seperate patientwise boxes. No shortage of drugs at any point & at any centre. 10.Strong system of Supervision- Provision of contractual S.T.S &S.T.L.S & one two wheeler with P.O.L.provided at T.U.level.

11. Strong system of accountability is in place.The resposibility of reporting patient’s outcome is that of the registering unit. 12.Goals are clearly defined ie- 85 % Cure rates & then 70 % case detection.

13.Monitoring & supervision from the level of C.T.D.to the level of T.B.Unit. 14.Concept of I.E.C. developed in the prog. Funds provided to theDistt.T.B.Socities.

15.N.G.O. Participation is being encouraged in a big way.Honest and dedicated N.G.Os are being invited to own one of the 5 schemes of the program.

R.N.T.C.P. The 5 commitments of R.N.T.C.P. Political commitment. Diagnosis by microscopy. Adequate supply of S.C.C. Drugs. Directly Observed Treatment. Accontabilility.

Goals of R.N.T.C.P % C U R E R A T E S And then % CASE DETECTION

Treatment Categories CAT-I 1.New Pulm.Smear Positive T.B.cases 2.Seriously ill Pulm.Smear Neg. & Extra –Pulm.Cases Regimen- 2(EHRZ)3 4(HR)3

CAT-2 Retreatment Cases- Relapse,Failure & Treatment after Default Cases. Regimen-2/3(SHERZ)3 5(HRE)

CAT-3 New Pulm Smear Neg T.B.Cases, New less Serious forms of Exrta Pulm T.B.Cases Reg.-2(HRZ)3 4(HR)

Directly Observed Treatment(DOTS) Why ? An observer watches and helps the patient swallow the tablets. Direct Observation ensures treatment for the entire course

IS THE TREATMENT OF The right Drugs In the right Doses & At the right interval

Ensure that:- 1.Treatment Observer must be accesible & acceptable to the Patient and accountable to the Health System 2.Observation is a service to the patients & providers

DOTS gives the desired results even when:- 1.Many patients do not take medicines regularly, even if excellent Health education is provided. 2.Impossible to predict which patient will take medicines

. Why is it necessary to Directly Observe the Treatment ? 1.At least 1/3 of patients receiving self administered treatment do not adhere to treatment. 2.Impossible to predict which patients will take medicines. 3.DOT necessary at least in the initial phase of treament to ensure adherence and achieve Sputum smear conversion. 4.A T.B. patient missing one attendance can be traced immediately and counseled.

Back To Part 1